Baxil Pharma Profile
Key Indicators
- Authorised Capital ₹ 3.00 Cr
as on 16-06-2024
- Paid Up Capital ₹ 1.00 Cr
as on 16-06-2024
- Company Age 18 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 5.50 Cr
as on 16-06-2024
- Satisfied Charges ₹ 2.00 Cr
as on 16-06-2024
- Revenue 20.12%
(FY 2023)
- Profit 503.33%
(FY 2023)
- Ebitda -8.12%
(FY 2023)
- Net Worth 0.11%
(FY 2023)
- Total Assets -0.73%
(FY 2023)
About Baxil Pharma
The Corporate was formerly known as Baviera Pharmaceuticals Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.00 Cr and a paid-up capital of Rs 1.00 Cr.
The company currently has active open charges totaling ₹5.50 Cr. The company has closed loans amounting to ₹2.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
Asha Singh, Anil Singh, and Virendra Sharma serve as directors at the Company.
- CIN/LLPIN
U24232DL2005PTC144166
- Company No.
144166
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 Dec 2005
- Date of AGM
14 Aug 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
New Delhi, Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Baxil Pharma Private Limited offer?
Baxil Pharma Private Limited offers a wide range of products and services, including Animal Medicines & Health Care, Veterinary Medicines, Anti Infective Drugs & Medicines, Antibiotic Tablets, Capsule & Syrup, Pain Relief Drugs & Pharmaceuticals, Anti Inflammatory Drugs, Nutraceuticals & Dietary Supplements, Multivitamin Syrup & Drops, Common Disease Medicines, Antihistamines.
Who are the key members and board of directors at Baxil Pharma?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Asha Singh  | Director | 28-Dec-2005 | Current |
| Anil Singh | Director | 28-Dec-2005 | Current |
| Virendra Sharma | Additional Director | 28-Dec-2023 | Current |
Financial Performance of Baxil Pharma.
Baxil Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 20.12% increase. The company also saw a substantial improvement in profitability, with a 503.33% increase in profit. The company's net worth moved up by a moderate rise of 0.11%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Baxil Pharma?
In 2023, Baxil Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Bhagwant Infra Developers Private LimitedActive 17 years 20 daysAsha Singh and Anil Singh are mutual person
- Concrete Technologies Private LimitedActive 26 years 4 months
Asha Singh and Anil Singh are mutual person
- Bhagwant Startup Forum And Incubation CentreActive 3 months 23 days
Asha Singh and Anil Singh are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Punjab National Bank Creation Date: 14 Jul 2010 | ₹3.00 Cr | Open |
Punjab National Bank Creation Date: 11 Jul 2007 | ₹2.50 Cr | Open |
Punjab National Bank Creation Date: 11 Jul 2007 | ₹2.00 Cr | Satisfied |
How Many Employees Work at Baxil Pharma?
Baxil Pharma has a workforce of 17 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Baxil Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Baxil Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
